Inhibitors for steroid response elements and RNA polymerase II and related methods
The present invention relates to polyamides capable of inhibiting ARE-, GRE- and ERE-mediated gene regulation in cells. The present invention also relates to polyamides capable of modulating the activity of RNA polymerase II and p53. The invention also relates to methods to treat diseases related to ARE-, GRE- and ERE-mediated gene regulation and to RNA polymerase II and p53 activity.
1. A polyamide of structure 1 as follows:
wherein each X is independently selected from CH, N, or COH; wherein each pyrrole unit of structure 2 as follows:
may be independently replaced by a beta-alanine of structure 3 as follows:
wherein each R 2 is independently selected from H, a C 1-5 alkyl, a C 1-5 alkenyl, a C 1-5 alkynyl; wherein R 3 is linked to R 4 through structure 4 as follows:
wherein R 1 is selected from structure 25 as follows:
and from structures 27 and 29-31, 37, 39-41 as follows:
and from structures 49-54 as follows:
wherein y is selected from structures 55-57 as follows:
wherein R 5 is selected from CH 3 and from structures 58-61 as follows:
wherein one of R 7 and R 5 is structure 7 as follows:
and the other one of R 7 and R 5 is selected from OH, SH, CH 3 , NH 2 , CH 2 CH 3 , NO 2 , COOH, COOMe, COOEt, halogen, F, Cl, Br, I, CH 2 F, CH 2 Cl, CH 2 Br, CH 2 I, CHF 2 , CHCl 2 , CHBr 2 , CHI 2 , CF 3 , CCl 3 , CBr 3 , and Cl 3 and from structures 8-13 as follows:
wherein R 11 is selected from OH, CH 3 , CH 2 CH 3 , and from structures 59-61 as follows:
wherein each R 14 represents one, two, three, four, or five sidechains up to the maximum number with each R 14 being independently selected from SH, CH 3 , CH 2 CH 3 , COOMe, COOEt, CH 2 Cl, CH 2 Br, CH 2 I, CHCl 2 , CHBr 2 , and CHI 2 ; and wherein each d, e, f, g, h, j, t is independently selected from 1-10, and the p adjacent to R 5 is 0 and the p adjacent to R 3 is 1.
2. The composition of claim 1 , wherein R 1 is selected from structures 40 and 41 as follows:
and from structures 49-54 as follows:
3. The composition of claim 1 , wherein each tetramer of the polyamide of structure 1 is independently selected from imidazole-imidazole-imidazole-pyrrole, imidazole-imidazole-pyrrole-pyrrole, imidazole-pyrrole-pyrrole-pyrrole, and imidazole-pyrrole-imidazole-pyrrole.
4. The composition of claim 1 , wherein one of R 7 and R 8 is structure 7 as follows:
and the other one of R 7 and R 8 is selected from structures 8-13 as follows:
5. The composition of claim 1 , wherein R 11 is selected from OH, and from structures 59-61 as follows:
6. The composition of claim 1 , wherein one of R 7 and R 8 is structure 7 as follows:
and the other one of R 7 and R 8 is selected from structures 8-13 as follows:
wherein R 11 is selected from OH, and from structures 59-61 as follows:
and wherein each R 14 represents one, two, three, four, or five sidechains up to the maximum number with each R 14 being independently selected from SH, CH 3 , CH 2 CH 3 , COOMe, COOEt, CH 2 Cl, CH 2 Br, CH 2 I, CHCl 2 , CHBr 2 , and CHI 2.
7. The composition of claim 1 , wherein said composition further comprises a pharmaceutically acceptable carrier.
8. The composition of claim 2 , wherein said composition further comprises a pharmaceutically acceptable carrier.
9. The composition of claim 6 , wherein said composition further comprises a pharmaceutically acceptable carrier.
10. The composition of claim 1 , wherein R 1 is selected from structures 49-54 as follows:
and wherein y is structure 57 as follows:
and wherein t is 1.
11. The composition of claim 1 , wherein R 1 is selected from structures 49-54 as follows:
and wherein y is structure 55 as follows: